Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Katarina Jovanović(Inserm), Salomon Manier(Centre National de la Recherche Scientifique), Guillaume Escure(Université de Lille), Alexandre Willaume(Hôpital Saint-Vincent-de-Paul), Bruno Quesnel(Inserm), Méryem-Maud Farhat(Université de Lille), Zoé Van de Wyngaert(Centre Hospitalier Universitaire de Lille), Thierry Façon(Inserm), Jordane Demonchy(Université de Lille), Paul Chauvet(Centre Hospitalier Universitaire de Lille)
Cited by 80
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
|Nature Communications|2014|906
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695